<DOC>
	<DOCNO>NCT02647424</DOCNO>
	<brief_summary>Polycystic ovary syndrome ( PCOS ) one common endocrinopathies , affect 5 % 10 % woman reproductive age . Women PCOS suffer anovulatory infertility . Following lifestyle modification weight reduction obese PCOS woman , clomifene citrate ( CC ) consider first line treatment ovulation induction ( OI ) woman . 75-80 % woman ovulate CC administration . However , discrepancy ovulation rate pregnancy rate , report 22 % per ovulate cycle CC . Other alternative , include gonadotropin injection laparoscopic ovarian drilling , carry different disadvantage , costly treatment risk ovarian hyperstimulation syndrome multiple pregnancy rate gonadotrophin therapy surgical risk risk ovarian failure surgical treatment . The use aromatase inhibitor , letrozole ( LTZ ) , reproductive medicine start 2001 . After publication , many group investigator study use LTZ either OI ovarian stimulation IVF cycle . A large multicentre randomize trial report significantly high ovulation rate live-birth rate compare LTZ CC . In majority publication , multiple pregnancy rate lower LTZ group CC group . This attribute high chance monofollicular development LTZ compare CC . However , information compare hormonal profile follicular development letrozole CC . Mild ovarian stimulation use LTZ CC conjunction intrauterine insemination commonly offer ovulatory woman unexplained infertility , minimal endometriosis mild factor improve pregnancy rate . There information compare hormonal profile follicular development letrozole CC ovulatory woman . The aim study compare hormonal profile use LTZ CC anovulatory PCOS woman ovulatory woman unexplained subfertility . The hypothesis FSH risk LTZ shorter CC .</brief_summary>
	<brief_title>A Comparison Letrozole Clomifene Citrate</brief_title>
	<detailed_description>Polycystic ovary syndrome ( PCOS ) one common endocrinopathies , affect 5 % 10 % woman reproductive age . Women PCOS suffer anovulatory infertility . Following lifestyle modification weight reduction obese PCOS woman , clomifene citrate ( CC ) consider first line treatment ovulation induction ( OI ) woman . 75-80 % woman ovulate CC administration . However , discrepancy ovulation rate pregnancy rate , report 22 % per ovulate cycle CC . Other alternative , include gonadotropin injection laparoscopic ovarian drilling , carry different disadvantage , costly treatment risk ovarian hyperstimulation syndrome multiple pregnancy rate gonadotrophin therapy surgical risk risk ovarian failure surgical treatment . The use aromatase inhibitor , letrozole ( LTZ ) , reproductive medicine start 2001 . After publication , many group investigator study use LTZ either OI ovarian stimulation IVF cycle . A large multicentre randomize trial report significantly high ovulation rate live-birth rate compare LTZ CC . In majority publication , multiple pregnancy rate lower LTZ group CC group . This attribute high chance monofollicular development LTZ compare CC . However , information compare hormonal profile follicular development letrozole CC . Mild ovarian stimulation use LTZ CC conjunction intrauterine insemination commonly offer ovulatory woman unexplained infertility , minimal endometriosis mild factor improve pregnancy rate . There information compare hormonal profile follicular development letrozole CC ovulatory woman . The aim study compare hormonal profile use LTZ CC anovulatory PCOS woman ovulatory woman unexplained subfertility . The hypothesis FSH risk LTZ shorter CC .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Enclomiphene</mesh_term>
	<mesh_term>Zuclomiphene</mesh_term>
	<mesh_term>Letrozole</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Inclusion criterion : Age woman 1839 year Irregular menstrual cycle anovulation ( cycle &gt; 35 day ) together polycystic ovary pelvic scan laboratory/clinical hyperandrogenism ( PCOS group ) Regular cycle 2535 day cycle ovulatory woman group Body mass index &lt; /= 30 kg/m2 Exclusion criterion : Couples undergo ART treatment cycle History ovarian surgery Drug allergy CC LTZ History diabetes mellitus severe medical disease Refusal join study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>